Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors

Drug Development Research(2022)10.1002/ddr.21971Source: DataRank Database

Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors is a research paper published in Drug Development Research (2022). On theSindex it has a DataRank of 0. It has been cited 54 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access54 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 6.20)OA: hybridTopics (47)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Devendra K. Agrawal ORCID,Harbinder Singh ORCID

Live enrichment

PubMed:35781678 PMC:PMC9474610 OpenAlex:https://openalex.org/W4283791224

National Institutes of Health

Grant: R01 HL144125

National Institutes of Health

Grant: R01 HL147662

National Institutes of Health

Grant: 5R01HL147662-04

Novel Molecular Target to Prevent Maturation Failure of Arteriovenous Fistula

National Institutes of Health

Grant: 7R01HL144125-03

Novel Approach to Stabilize Atherosclerotic Plaque in Carotid Artery

FWCI

6.20

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ddr.21971

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ddr.21971

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21971

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/ddr.21971

publisherhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21971

Fields of Study

Advanced Glycation End Products researchMangiferin and Mango Extracts0301 basic medicine0303 health sciences03 medical and health sciencesDiabetes MellitusGlycation End Products, AdvancedHumansLigandsReceptor for Advanced Glycation End ProductsSignal Transduction

MeSH Terms

Receptor for Advanced Glycation End ProductsDiabetes MellitusHumansLigandsSignal TransductionGlycation End Products, Advanced

Keywords

Rage (emotion)GlycationReceptorTransmembrane proteinSignal transductionMedicineInflammationImmune systemNeuroscienceImmunologyBioinformaticsCancer researchBiologyCell biologyInternal medicineInhibitorAntagonistAGEsS100 ProteinsChronic Inflammatory DiseasesRageEndogenous LigandsRage IsoformsExogenous LigandsGlycation End Products, AdvancedReceptor for Advanced Glycation End ProductsDiabetes MellitusHumansReview ArticleLigands

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being